Are McDonald's Wings a Sign of Desperation?

Jan. 8 (Bloomberg) -- Miller Tabak Senior Analyst Stephen Anderson talks about McDonald’s testing their new "Mighty Wings" in Chicago this week and his outlook for the company. He speaks on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month
09:34 - Pfizer and Merck KGaA’s cancer immunotherapy won approval from U.S. regulators for patients with a rare form of skin cancer, and the companies plan to sell the drug for $13,000 a month. Merck KgaA CEO Stegfan Oschmann speaks on "Bloomberg Daybreak Europe." (Source: Bloomberg)
  • Aviva's Diebel Sees No Macro Impact From Healthcare Bill
  • Italy Junior Minister Sees Brexit as EU Opportunity
  • French Presidential Race Takes an Inflammatory Turn